News Research Gastrointestinal Cancers Prognostic & Predictive Models

Multimodal Deep Learning for First-Line Immunotherapy Response in Gastric Cancer

A multimodal AI model predicted anti–PD-(L)1 therapy response and survival in gastric cancer and identified associated immune-related biologic signatures.

April 28, 2026 By Julia Cipriano, MS, CMPP 5 min read
Share

0 Key Takeaways

ASCO AI in Oncology is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.

KOL Commentary
Watch

Related Content